News Headlines Article

FDA finds safety woes at compounding pharmacies; hearing next week
Modern Healthcare

Air filters marked with dark-amber stains, unexplained variations in drug purity, patients’ complaints dismissed without investigation: All were among the deficiencies cited at 31 drug-compounding factories inspected in the past seven weeks by the Food and Drug Administration.

In the wake of last year’s deadly outbreak of drug-borne fungal meningitis, the FDA has undertaken an aggressive inspection program at higher-risk facilities around the country that produce the sterile compounded drugs on which many hospitals rely.